TBG Diagnostics, Medigen and National Taiwan University Hospital enter Exclusive Licensing Agreement for the Development and Distribution of Patented Product for Evaluation of Adverse Reaction in Antithyroid Drug.
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
http://www.aspecthuntley.com.au/asxdata/20170313/pdf/01838094.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
